Price movement over the last 24 hours
Aave vs Injective — how do they compare? Aave trades at Rp1,587,714 (market cap Rp24,54T, Rp4,08T 24h volume), while Injective trades at Rp83,895 (market cap Rp8,37T, Rp1,26T 24h volume). The key difference: Aave is far larger — about 2.9× Injective's market cap, and Aave's circulating supply is 15,4M AAVE versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Aave for 102 Days and Injective for 36 Days on average.
| AAVE | INJ | |
|---|---|---|
Market Cap | Rp24,54T | Rp8,37T |
Volume (24h) | Rp4,08T | Rp1,26T |
Circulating Supply | 15,4M AAVE | 100M INJ |
Typical Hold Time | 102 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Aave (AAVE) is trading at Rp1,572,179 with a market cap of Rp24.14T, showing a bullish technical signal driven by moving averages. The current price sits above key support levels, with RSI in neutral territory. Recent protocol upgrades and ecosystem growth, such as the deployment on new chains, support fundamental strength.
Overall outlook is cautiously optimistic, with opportunities in DeFi adoption and protocol innovation. Major risks include high volatility, regulatory uncertainty in crypto, and liquidity fluctuations. Investors should monitor on-chain activity and broader market trends.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
AAVE is one of the biggest and earliest decentralized finance protocols. It enables users to lend and borrow a wide range of cryptocurrencies using both fixed and variable interest rates.
Read more on AAVE →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →